Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(26 sites)

China

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing Municipality

Fujian Medical University Union Hospital, Fuzhou, Fujian

Fujian Provincial Hospital, Fuzhou, Fujian

Gansu Provincial Hospital, Lanzhou, Gansu

Dongguan People's Hospital, Dongguan, Guangdong

First People's Hospital of Foshan, Foshan, Guangdong

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong

First Affiliated Hospital of Jinan University, Guangzhou, Guangdong

Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong

Wuhan TongJi Hospital, Wuhan, Hubei

Wuhan Union Hospital, China, Wuhan, Hubei

Jiangsu Cancer Institute & Hospital, Nanjing, Jiangsu

The General Hospital of Eastern Theater Command, Nanjing, Jiangsu

The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu

The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu

Tang-Du Hospital, Xi'an, Shaanxi

Shandong Provincial Hospital, Jinan, Shandong

The Affiliated Hospital of Qingdao University, Qingdao, Shandong

RenJi Hospital, Shanghai, Shanghai Municipality

Shanghai Changzheng Hospital, Shanghai, Shanghai Municipality

Sichuan Cancer Hospital and Research Institute, Chengdu, Sichuan

West China Hospital, Chengdu, Sichuan

Suining Central Hospital, Suining, Sichuan

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality

Tianjin Chest Hospital, Tianjin, Tianjin Municipality

First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan